Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
ConditionRefractory Melasma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorEgymedicalpedia
About this trial
Melasma is a common acquired disorder of hyperpigmentaion caused by increased melanin production by melanocytes.
Melasma is a name derived from the Greek word melas meaning black.It is characterized by the appearance of brownish or grayish symmetrical patches on sun-exposed skin, most commonly on the face. Compared to men, women are more likely to be affected.
Eligibility criteria
Qualifiers
None
Disqualifiers
Pregnancy
Lactation
Administration of oral contraceptive pills or any phototoxic drug within 1 month prior to study
Patients with a history of thrombosis, abnormal bleeding profile, known hypersensitivity to TA or HQ, and endocrinal disease.
Trial design
Treatments tested in this trial
- Tranexamic acid injection
Treatment groups
45 Participants
are divided into 3 treatment groupsSponsors and collaborators
Egymedicalpedia
Lead sponsor
Aswan University
Collaborator
Source ClinicalTrials.gov